Results 131 to 140 of about 124,134 (216)

Plasma Cell Mucositis: A 20‐Year Retrospective Review at a Tertiary Center

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Plasma cell mucositis (PCM) is a rare, chronic inflammatory condition of mucosal surfaces that is likely underdiagnosed and underreported, with limited data on its clinical characteristics, extracavitary involvement, and treatment outcomes.
Miguel A. Aristizabal‐Torres, Jessi M. Larrinaga, Katherine Bodiford, Olayemi Sokumbi, Leila Tolaymat   +4 more
wiley   +1 more source

Genetics and Molecular Mechanisms in Oral Squamous Cell Carcinoma: A Narrative Review. [PDF]

Medicina (Kaunas)
Ionescu C, Anton ET, Rarinca V, Visternicu M, Ciobîcă A, Novac B, Tomița D, Hogas M.   +7 more
europepmc   +1 more source

The Effects of an Educational Video on Patient Understanding of Amelanotic Melanoma

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Amelanotic melanoma (AM) is a subset of melanoma with little to no pigment that can masquerade as a benign condition, and is associated with delayed diagnosis, greater Breslow depth, higher tumour stage, and lower survival than pigmented melanoma.
Aria Wei, Bilal Haque, Kamil Taneja, Stephanie Savory   +3 more
wiley   +1 more source

The oral microbiota in oral squamous cell carcinoma: unravelling mechanisms and clinical potential. [PDF]

Cancer Cell Int
Kamel AHM, El-Tantawy N, Ahmed S, Wadan AS, AbuBakr N.   +4 more
europepmc   +1 more source

Integrated Bioinformatic and Molecular Characterization of the miR-4303/miR-4291-MAPK1 Axis in Oral Squamous Cell Carcinoma. [PDF]

Cancer Inform
Bagheri Farahani S, Noghrei H, Jamshidian F.   +2 more
europepmc   +1 more source

Rhaponticin Blocks Glycolysis‐Mediated Histone Lactylation to Suppress Tongue Squamous Cell Carcinoma via HIF‐1α Activity Inhibition

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Tongue squamous cell carcinoma (TSCC) often develops therapeutic resistance. Metabolic reprogramming, particularly the glycolysis/lactate/histone lactylation axis, is a critical driver of tumor progression and therapy resistance. This study investigated the anti‐tumor mechanism of Rhaponticin (Rha), focusing on the metabolic/epigenetic axis ...
Yuan Wu, Liang‐Liang Yao, Lin Jiang, Zhi‐Yi Fang, Jia‐Jun Zhu, Yi‐Sen Shao, Wen‐Juan Wang, Xiao‐Wen Wan   +7 more
wiley   +1 more source

Correction: Identification of potential biomarkers for oral squamous cell carcinoma through multi-cohort bioinformatic analysis. [PDF]

J Egypt Natl Canc Inst
Kamei D, Kaur S, Priya A, Bansal A, Yadav A, Ray AK, Agrawal Y.   +6 more
europepmc   +1 more source

Heterogeneity Analyzed by CT‐Based Habitat Analysis for Clinical Management of Cancers: A Narrative Review

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Tumors are highly heterogeneous, and whole‐lesion radiomics analysis is a popular method for extracting texture features that reflect this heterogeneity, which can be used to build models for cancer diagnosis, staging, therapy response evaluation, and prognosis prediction.
Yang Zhang, Zhi‐Yan Jin, Min‐Ying Lydia Su   +2 more
wiley   +1 more source

Association of NAP1L1 polymorphism with clinicopathological progression in oral squamous cell carcinoma. [PDF]

J Cancer
Hsieh MJ, Ho HY, Lo YS, Kao MY, Lin CC, Chuang YC, Chen MK.   +6 more
europepmc   +1 more source

Triptolide Suppresses Tongue Squamous Cell Carcinoma Progression via PI3K–AKT Pathway Inhibition: An Integrative Network Pharmacology and Experimental Validation Study

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Tongue squamous cell carcinoma, the most aggressive subtype of oral squamous cell carcinoma, which is associated with high mortality, frequent recurrence, and early lymph‐node metastasis. Triptolide, a bioactive diterpenoid from Tripterygium wilfordii, exhibits broad anticancer activity.
Shan‐Shan Wang, Hong‐Cheng Wei, Lin Jiang, Yi‐Sen Shao   +3 more
wiley   +1 more source